Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Jae Cho

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Genetics|November 9, 2023
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastomaOwen S Chapman, Jens Luebeck, Sunita Sridhar, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
Nature Genetics|July 3, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaDavid T W Jones, Barbara Hutter, Natalie Jäger, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Nature Neuroscience|May 20, 2020
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastomaAlexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, et al.
Nature Genetics|November 9, 2023
Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastomaOwen S Chapman, Jens Luebeck, Sunita Sridhar, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
Nature Genetics|July 3, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaDavid T W Jones, Barbara Hutter, Natalie Jäger, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
Pageof 13